{"url_path":"/sec/asbp/10-q/2026/item-4","section_key":"item-4","section_title":"Item 4 MINE SAFETY DISCLOSURES**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1847345/0001493152-26-023802-index.html","accession_number":"0001493152-26-023802","cik":"0001847345","ticker":"ASBP","issuer_name":"Aspire Biopharma Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1847345/0001493152-26-023802-index.html","primary_entity_key":"0001847345","primary_entity_name":"Aspire Biopharma Holdings, Inc."},"word_count":6,"has_tables":true,"body_markdown":"**ITEM 4. MINE SAFETY DISCLOSURES**\n\n \n\nNone"}